Abnormal GABAergic interneuron density, and imbalance of excitatory versus inhibitory tone, is thought to result in epilepsy, neurodevelopmental disorders, and psychiatric disease. Recent studies indicate that interneuron cortical density is determined primarily by the size of the precursor pool in the embryonic telencephalon. However, factors essential for regulating interneuron allocation from telencephalic multipotent precursors are poorly understood. Here we report that Olig1 represses production of GABAergic interneurons throughout the mouse brain. Olig1 deletion in mutant mice results in ectopic expression and upregulation of Dlx1/2 genes in the ventral medial ganglionic eminences and adjacent regions of the septum, resulting in an $30% increase in adult cortical interneuron numbers. We show that Olig1 directly represses the Dlx1/2 I12b intergenic enhancer and that Dlx1/2 functions genetically downstream of Olig1. These findings establish Olig1 as an essential repressor of Dlx1/2 and interneuron production in developing mammalian brain.
INTRODUCTION
The balance between excitatory and inhibitory tone in the cerebral cortex is mediated largely by relative activity of excitatory glutamatergic pyramidal cells and inhibitory g-aminobutyric acid-containing (GABAergic) local circuit neurons, also known as interneurons (INs) . GABAergic INs regulate sensory fields, plasticity, and the frequency and tone of cortical oscillatory activity (Alonso and Swadlow, 2005; Kehrer et al., 2008; Lehmann et al., 2012; Lewis et al., 2005; Lliná s et al., 2005; Schiller and Tehovnik, 2005) . Disruption of excitatory/inhibitory balance is linked to epilepsy, neurodevelopmental, and psychiatric disorders (Ben-Ari, 2006; Cobos et al., 2005; Corbin et al., 2001; Han et al., 2012; Hashimoto et al., 2003 Hashimoto et al., , 2008 Kehrer et al., 2008; Rossignol, 2011; Rubenstein, 2010; Rubenstein and Merzenich, 2003; Yizhar et al., 2011) .
A recent study suggests that the size of the cortical IN population is determined primarily in the early embryo at time of specification, rather than by neurotrophic competition, and programmed cell death later in development (Southwell et al., 2012) . Transplanted IN precursors are capable of functional integration into the adult brain (Alvarez-Dolado et al., 2006; Southwell et al., 2010) and can attenuate seizures in rodent models of epilepsy (Baraban et al., 2009; Hunt et al., 2013) . Increased IN population size also induces and extends critical periods for ocular dominance plasticity (Southwell et al., 2010) . Thus, generating the appropriate number of cortical neurons during development is crucial. However, the factors that normally limit the size of the IN progenitor pool are poorly understood and essential repressors of IN developmental programs have not been described.
Specification of cortical inhibitory neurons from multipotent precursors in the embryonic brain is complex, involving the following: (1) patterning of spatially discrete progenitor pools for specific subtypes, (2) temporal regulation of multiphase neurogenesis, and (3) mechanisms of neuron versus oligodendroglial (OL) cell fate acquisition (Butt et al., 2005; Kessaris et al., 2006; Marín, 2012; Wonders et al., 2008) . Cortical inhibitory neurons are produced from E10 to E17 in the medial ganglionic eminence (MGE), anterior entopeduncular area (AEP; a ventral region of the MGE), caudal ganglionic eminence (CGE), and preoptic areas (POA) of the ventral telencephalon; they then migrate tangentially into the cerebral cortex (Anderson et al., 1997; Corbin et al., 2001; Miyoshi et al., 2007; Wonders and Anderson, 2006) . Parvalbumin (PV) and calretinin (CR) positive cells are derived relatively late in embryogenesis from progenitor domains that produce both OLs and INs, whereas neuropeptide-Y (NPY) and somatostatin (SST) subtypes are born prior to the onset of OL specification (Kessaris et al., 2006; Miyoshi et al., 2007; Taniguchi et al., 2013; Wonders et al., 2008) . In contrast, the adjacent regions of the lateral ganglionic eminence and the telencephalic septum generate neurons of the ventral forebrain and olfactory bulb (OB) but are not thought to give rise to cortical INs (He et al., 2001; Kessaris et al., 2006; Petryniak et al., 2007; Rubin et al., 2010) . Dlx1/2 function is necessary for the establishment of IN cell production within these regions and differentiation into GABAergic INs (Anderson et al., 1997) . Though the mechanisms that control OL versus IN fate are poorly understood, we have shown that Dlx1/2 function is required in the MGE and AEP to control the neuron-glial switch, promoting neurogenesis at the expense of OLs through repression of Olig2 (Petryniak et al., 2007) . In contrast, Olig2-null animals show no abnormalities in early IN development (Petryniak et al., 2007; Furusho et al., 2006; Ono et al., 2008) .
Olig1 is expressed in the embryonic neuroepithelium of the ventral forebrain (Petryniak et al., 2007) , which can give rise to INs and OLs (Mukhopadhyay et al., 2009; Samanta et al., 2007) . However, Olig1 function is generally thought to be limited to late stages of OL development to promote differentiation (Lu et al., 2002; Xin et al., 2005) and remyelination (Arnett et al., 2004) . Here, we show a surprising role for Olig1 as an upstream repressor of Dlx1/2 and GABAergic IN production in the embryonic brain, establishing that Olig1 functions in the regulation of the neuron-glial switch. Loss of Olig1 derepresses production of late CR and PV IN subtypes in ventral MGE, AEP, and regions of the MGE connected to the septum, resulting in a 30% excess of INs in adult cortex. Postnatally, Olig1-null neural progenitors produced excessive numbers of INs and are deficient in OL production. We show Olig1 directly binds and represses the I12b enhancer element, a known Dlx1/2 intergenic cis-acting DNA regulatory sequence, and using a newly generated floxed conditional Dlx1/2 knockout allele, we show that Dlx1/2 lies genetically downstream of Olig1.
Together, these findings demonstrate that Olig1 is an essential repressor of GABAergic neuron production in the mammalian brain.
RESULTS
Inhibitory IN Numbers Are Increased in the Cortex of Olig1-Null Animals To assess Olig1-dependent regulation of IN production, we first analyzed IN markers in the adult (P50) motor and somatosensory cortex of Olig1-null and control animals by immunohistochemistry (IHC) ( Figure 1A ). Evaluation of IN subtypes in motor and somatosensory cortex demonstrated that there was an approximate 35% increase in PV+ and CR+ IN subtypes, but not SST+ or NPY+ subtypes (Figures 1B, and 1M) . We also observed an $30% increase in cells expressing the pan-IN lineage markers GABA and GAD67 (Figures 1G and 1H ; Figures S1K and S1L available online). We next determined if the laminar distribution of INs was abnormal. Increased numbers of PV+ and CR+ INs were present throughout the cortical layers. We did not find any difference in the laminar distribution of SST+ and NPY+ cells ( Figures 1N-1Q ). SST+ and NPY+ neurons are generated early in telencephalic neurogenesis before E13. In contrast, CR+ neurons are generated at later stages and the PV+ subtype is generated throughout embryogenesis, coinciding with the onset of OL specification (Kessaris et al., 2006; Miyoshi et al., 2007; Taniguchi et al., 2013; Wonders et al., 2008) . Thus, Olig1 acts to limit late-born INs generated simultaneously with OLs, but not early-born INs. Normal numbers of glutamatergic and cholinergic neurons were observed in Olig1-null animals (data not shown).
To confirm our findings, we conducted unbiased stereological analysis of the number of GAD67+ cells throughout the cortex and determined that the density and estimated total number of GAD67+ cells was increased by $25% throughout the cortex (Figures S1K-S1L). Cortical volume was unchanged in Olig1-null mice (Figures 1B and S1M) . To ensure that our results are not due to misexpression of IN markers with other cell types, we performed IHC for PV and GAD67 with markers of pyramidal cells (Tbr1), OLs (Olig2), microglia (Iba1), and astrocytes (GFAP). As shown (Figures S1G-S1J), we found no instance of abnormal IN marker expression in Olig1 À/À brains.
Inhibitory PV+ INs synapse on the soma of cortical pyramidal cells, whereas CR+ neurons synapse mainly on the soma of other INs (Caputi et al., 2009; Freund and Buzsá ki, 1996; Gonchar and Burkhalter, 1999) . In keeping with the counts described above, we found an $30% increase of PV+ puncta on the soma of layer 2/3 and 5/6 pyramidal neurons of somatosensory and motor cortex ( Figures 1C and 1D) . Moreover, such puncta also expressed vesicular GABA transporter (VGAT) ( Figure 1E ), a marker of inhibitory synapses (Bragina et al., 2007) . Quantification of VGAT+ puncta in dendritic fields revealed no differences in the number of inhibitory synapses on dendrites, consistent with our finding that SST+ cell numbers are not affected in Olig1 À/À mice ( Figures 1E and 1F ).
Increased IN Number Does Not Alter Inhibitory Events on Cortical Pyramidal Cells: Evidence of Postsynaptic Gephyrin-Mediated Compensation
There are a myriad of cell-intrinsic and synaptic homeostatic mechanisms that control inhibition in cortical circuits (Pozo and Goda, 2010; Turrigiano, 2011 GABAergic activity (Poulopoulos et al., 2009; Prior et al., 1992; Saiepour et al., 2010; Tretter et al., 2008 Tretter et al., , 2012 . As demonstrated ( Figure S2C ), we observed normal numbers of gephyrin puncta identified by IHC at the postsynapse. We also noted that some CR+ INs make inhibitory connections with other INs, and thus, excess CR+ INs may also limit the activity of other IN subtypes . Cell counts were taken from micrographs of S2 and primary M1 (For all quantifications, mean ±SEM; n = 3-4; *p < 0.05, **p < 0.01, ***p < 0.005; two-tailed unpaired Student's t test). In (B'), (E'), and (K''), scale bar indicates 50 mm; in (C') and (K''), scale bars indicate 5 mm, and in (E'), scale bar indicates 15 mm. in Olig1 À/À mice (Caputi et al., 2009; Freund and Buzsá ki, 1996; Gonchar and Burkhalter, 1999) .
Olig1 Represses Neurogenesis in the Cerebellum and OB
We next assessed Olig1 function in the cerebellum (CB) and OB, brain areas that exhibit protracted neurogenesis (Maricich and Herrup, 1999; Schü ller et al., 2006) . As shown (Figures 2A-2C and 2D), we observed an $30% surplus of AP2Beta+ and Pax2+ cerebellar INs at P7 and P21, respectively. Robust neurogenesis and neural cell turnover persists in the OB throughout life and is regulated by Dlx1/2 (Alvarez- Buylla et al., 2002; Long et al., 2007) . To assess neurogenesis in the OB, we conducted birth dating assays by injecting the thymidine analog Bromodeoxyuridine (BrdU) intraperitoneally into P2 pups and analyzing OBs in tissue harvested by perfusion at P50. These mice exhibited approximately 2-fold increases in the numbers of BrdU+ cells in the granule layer and glomerular layer ( Figures   2F-2J ). In summary, these findings provide evidence that Olig1 has a general role in repressing IN production, including in the neocortex (PV+ and CR+ subtypes), CB (Pax2+ / AP2Beta+), and perinatal OB.
Olig1
-/-Mice Produce Fewer Numbers of Oligodendrocytes Given previous evidence for common precursor domains for INs and OLs in the embryonic telencephalon, perinatal CB, and OB throughout life (Goldman et al., 1997; Menn et al., 2006; Petryniak et al., 2007; Silbereis et al., 2009; Zhang and Goldman, 1996) , we assessed the impact of Olig1 loss of function on the OL population in the adult cerebral cortex and CB by histological analysis. The numbers of cells expressing the pan-OL marker Olig2, as well as the mature OL markers PLP and APC, are all reduced in the corpus callosum, motor cortex, and cerebellar white matter of the P21 and P50 mouse brain (Figures S1A-S1F). 
Olig1 Is Expressed in Multipotent Telencephalic
Progenitors that Produce Cortical IN GABAergic INs of somatosensory and motor cortex develop from the ventral embryonic telencephalon under control of Dlx1/2 and other transcriptional programs (Anderson et al., 1997; Wonders and Anderson, 2006) . As shown ( Figures 3A-3D ), we detected Olig1 mRNA transcripts in the AEP and ventral MGE telencephalic regions that express Dlx1/2 (Petryniak et al., 2007) , as well as caudal/dorsal regions of embryonic septum, which produces OLs but is not thought to produce cortical INs (Rubin et al., 2010) . Nkx2.1 is a hedgehog-responsive gene critical for establishing progenitors of ventral identity that derive both forebrain OLs and INs (Butt et al., 2008; Elias et al., 2008; Kessaris et al., 2006; Maricich and Herrup, 1999 Figures 4A-4H ). To quantify this upregulation and assess the expression of Vax1 and Sp8 (two additional genes associated with IN production in the telencephalon), we dissected the caudal septum, AEP, and ventral MGE from wild-type and Olig1-null embryos and performed qPCR (Anderson et al., 1997; Taglialatela et al., 2004; Waclaw et al., 2006) . We observed 2-fold to 4-fold increased expression of Dlx2, Vax1, and Sp8 ( Figure 4I ). These data indicate that loss of Olig1 function results in upregulated expression of key transcription factors that drive IN cell fate acquisition. Previously, gain-of-function studies have shown that Olig1 promotes OL specification from neural progenitors (Kim et al., 2011; Lu et al., 2000 Lu et al., , 2001 Maire et al., 2010) . To assess potential changes in embryonic OPC production, we assessed PDGFRa+ cells by ISH and quantified Sox10+ OPCs by IHC in Olig1 À/À mutant and wild-type E15 embryos in the mantle of the ventral telencephalon. This showed a reduction in OPC number ( Figures S3A-S3C ). In contrast, we observed no significant change in levels of the mitotic cell marker phospho-histone H3 (PH3) in the septum, MGE, and AEP ( Figures S3D-S3F ). Together, these findings suggest that Olig1 function is required to promote OPC production at the expense of INs in the ventral telencephalon, but it does not regulate IN precursor proliferation. Further, this shows a unique function of Olig1 as a repressor of IN development, because Olig2-null mice, which lack OPCs, show normal expression of Dlx2 (Petryniak et al., 2007) and IN precursor numbers identified by expression of GAD67 mRNA in the ventral telencephalon ( Figure S4 ) (Furusho et al., 2006; Ono et al., 2008) .
To confirm the birthdate of ectopic cortical INs in the Olig1 mutant embryonic forebrain, we injected bromodeoxyuridine (BrdU) into pregnant dams at E16. BrdU colabeling analyses with PV and GABA revealed an approximately 30% increase in the number of INs generated at these ages ( Figures 4J-4O) . Interestingly, at P0 we observed enhanced expression of Dlx2 in the subventricular zone (SVZ) of Olig1-null animals ( Figures  S5A-S5D) , raising the possibility of persistent IN production. However, BrdU birth dating at P2 ruled this out ( Figures S5E and  S5F ). Together, these findings indicate that Olig1 regulates neuron-glial fate choice in the embryonic telencephalon.
Postnatal Roles for Olig1 in Suppression of IN Production
The finding of increased OB neurogenesis perinatally and ectopic Dlx2 expression in Olig1-null dorsal SVZ at P0 suggested there may be persistent roles for Olig1 in neural stem cells (NSCs). To test if Olig1 regulates cell fate in defined culture conditions, we harvested progenitors from P3 anterior SVZ and then cultured progenitor cells as neurospheres or adherent monolayers of NSCs. Neurospheres were expanded in EGF and FGF and then transferred to factor-free medium overnight to induce differentiation markers. Western blot analysis of total proteins demonstrated increased levels of neuron-specific Tuj1 and Dlx2 expression in Olig1-null neurospheres compared to wild-type; in contrast, Olig2 levels were dramatically reduced ( Figure 5A ). In keeping with these findings, Olig1-null spheres showed enhanced capacity to produce young doublecortin (DCX)+ neurons ( Figure 5B ). As shown ( Figures 5C-5E ), Olig1 loss of function enhanced GABAergic IN production from NSC monolayer cultures. By contrast, monolayers derived from Olig1-null progenitors were deficient in production of NG2+, O4+, and GalC+ OL lineage cells (Figures 5F-5I ), which respectively label OPCs, premyelinating OLs, and myelinating OLs. GFAP+ astroglial production was unaffected (data not shown). Thus, Olig1 function is required in cultured postnatal neural progenitors to repress IN production and preserve oligodendrogenesis.
Evidence that Olig1 Is a Direct Repressor of the Dlx1/2 I12b Intergenic Enhancer Olig1 acts as a transcriptional repressor (Lee et al., 2005; Novitch et al., 2001; Sun et al., 2003) . Thus, we hypothesized that Olig1 might directly repress Dlx1 and/or Dlx2, which colocalize within 10 kb of each other on mouse chromosome 2. This potential hierarchy is consistent with the observations that (1) Olig1-cre fate mapping labels 30% of cortical GABAergic neurons, (2) Olig1 protein shows segregated expression from Dlx2 in ventral telencephalon (Figure 6a ), and (3) the previous finding that Dlx1/2-cre fate mapping fails to label Olig1-positive cells (Potter et al., 2009) .
We tested whether Olig1 might regulate cis-acting DNA regulatory sequences in the intergenic region of Dlx1/2. Activity of the I12b enhancer drives expression of Dlx1/2 in the embryonic ventral telencephalon Park et al., 2004; Poitras et al., 2007) . We determined that the I12b enhancer contains three E-box sites, the canonical binding sequences for bHLH transcription factors including Olig1 (Figures 6B,  S6A , and S6B). We then used electrophoretic mobility shift assays (EMSA) to test Olig1 binding to Dlx1/2 I12b E-box sites in vitro. As shown in Figures 6C and 6D , purified Olig1 proteins shifted E-boxes 1 and 3, with the highest affinity for E-Box 1.
Binding to E-box 1 was dose dependent and was abrogated by DNA mutation of E-box sites within the I12b enhancer ( Figures  6C, 6D , and S6B). Specificity of Olig1 binding was further tested by supershift assays, which demonstrated that treatment with an antibody against Olig1, but not with a control IgG antibody, inhibits binding of Olig1 protein to enhancer DNA sequences ( Figures 6E and 6F) .
To confirm that Olig1 acts as a repressor of Dlx1/2, we next used a luciferase assay by cloning the I12b enhancer into the pGL4 luciferase construct (Promega) and transfecting it into P19 cells. Because Dlx1/2 are positive feedback regulators of their own expression via the I12b locus (Potter et al., 2009 ), we transfected a Dlx2 expression construct to induce I12b-dependent luciferase activity. When an Olig1 expression construct was transfected into these cells, it induced a nearly 3-fold reduction in luciferase activity ( Figure 6G ). Together, these 
Genetic Functions of Dlx1/2 Downstream of Olig1
We next tested whether Dlx1/2 function lies genetically downstream of Olig1. We generated a conditional floxed allele that removes Dlx1 exons 2 and 3, the intergenic region, and Dlx2 exons 2 and 3 upon exposure to cre recombinase ( Figure 7A ). Targeted ES cells produced chimeras that passed the allele through the germline ( Figures 7B and 7C (K-M) Quantification of the number of GABA+, Tuj1+, and PDGFRa+ cells, respectively, in NSC monolayer cultures (mean ±SEM; n = 3 experiments; 2-slide wells per experiment; *p < 0.05; **p < 0.01, two-tailed unpaired Student's t test). In (E''), scale bar indicates 50 mm. See also Figure S7 . and 7M). Taken together, these genetic findings support a model in which Olig1 acts as an essential repressor of Dlx1/2 to limit IN pool size and promote oligodendrogliogenesis ( Figure 8A ).
DISCUSSION
Recent studies indicate that the number of adult cortical INs is determined primarily at time of specification in the embryonic telencephalon, rather than through later neurotrophic competition, and developmental cell death (Southwell et al., 2012) . Thus, limiting the number of cortical neurons produced during development is crucial. Here we show that Olig1 represses Dlx1/2 and IN production while preserving the potential to generate oligodendrocytes from common progenitors of the developing brain ( Figure 8A ).
Olig1 Functions as an Essential Repressor of IN Production in Mammalian Brain
We identified Olig1 as a determinant of IN precursor pool size and IN numbers in the adult murine cortex. We observed an approximate 30% expansion of the total IN population, confined to PV+ and CR+ IN cell types, and a similar increase in PV/VGAT synapse density. This is consistent with previous findings that the maximum increase in density after transplantation of similar MGE progenitors into cortex is $30% above normal (Baraban et al., 2009; Southwell et al., 2010 Southwell et al., , 2012 . Based on these studies, it was unclear whether increased endogenous generation of INs in Olig1 À/À mice would affect inhibitory activity on pyramidal cells. Indeed, we found that increased IN cortical density in Olig1-null mice did not induce changes in the number of inhibitory potentials on pyramidal cells in adult mouse cortex. This may reflect the increase in CR+ cells, which make inhibitory synapses on other INs (Caputi et al., 2009; Freund and Buzsá ki, 1996; Gonchar and Burkhalter, 1999) . It is also notable that expression of the postsynaptic scaffolding protein gephyrin is unaltered in Olig1-null mice. Gephyrin regulates the recruitment, stability, and clustering of GABA receptors at the postsynapse and is downregulated by increased inhibitory activity Poulopoulos et al., 2009; Prior et al., 1992; Saiepour et al., 2010; Tretter et al., 2008 Tretter et al., , 2012 Vlachos et al., 2012) . These data suggest that the increased interneuron number in Olig1 À/À mice might result in gephyrin-dependent postsynaptic compensation. We further demonstrated that Olig1 is necessary to limit IN production in the CB and OB. Though numerous genes are required for IN specification and expansion, this is, to our knowledge, the first example of a transcription factor that represses cortical IN number.
Olig1 Regulates Neuron-Glial Fate Choice
The expansion of cortical IN number in Olig1 À/À animals suggested a critical role in regulating embryonic neurogenesis. Olig1 is not robustly expressed in forebrain until E12.5 (Lu et al., 2002) , a time point that coincides with the onset of oligodendrocyte specification (He et al., 2001; Kessaris et al., 2006) . Indeed, several lines of evidence support the hypothesis that Olig1 regulates the neuron-glial switch. First, Olig1 is coexpressed in Nkx2.1+ and Nestin+ multipotent radial glia. Second, we observed upregulation of pro-IN gene expression in ventral MGE and AEP of Olig1 À/À animals (e.g., Lhx6 and Dlx1/2), coupled with decreased OPC production in the ventral telencephalon. A surprising finding of the study was that the septum appears competent to produce INs in the absence of Olig1 function ( Figure 8B ). Finally, Olig1 limits production of PV+ and CR+ cells, which are derived late in embryogenesis from progenitor domains that produce both OLs and INs, but not NPY+ and SST+ cells, which are born prior to the onset of OL specification (Kessaris et al., 2006; Miyoshi et al., 2007; Taniguchi et al., 2013; Wonders et al., 2008) . In support of broad roles for Olig1 in neuron-glial fate choice, we found enhanced neurogenesis in the CB and SVZ/OB. Taken together, our findings suggest that Olig1 acts in regions of protracted neurogenesis to limit IN production and promote OPC specification in several brain regions.
Olig1 Regulates Cell Fate Choice in Multipotent
Progenitors through Repressive Interactions with Dlx1/2 DNA binding and luciferase assays suggest that Olig1 is a direct repressor of the Dlx1/2 locus acting through E-boxes in the I12b intergenic enhancer (Ghanem et al., 2003 Park et al., 2004; Poitras et al., 2007 genes that control interneuron production in the CB and other brain regions. Despite similar structural features, Olig1 and Olig2 are functionally distinct in many respects (Meijer et al., 2012) , including expression pattern, posttranslational modification, cofactors, and transcriptional targets (Li et al., 2007; Li and Richardson, 2008; Lu et al., 2012) . Our data show another unique role of Olig1 as an essential repressor of IN development. Prior studies show that forced Olig1 overexpression results in ectopic OPC specification from neural progenitors (Kim et al., 2011; Lu et al., 2000 Lu et al., , 2001 Maire et al., 2010) . Although Olig2 shows more robust expression than Olig1 in the MGE and binds E-boxes in the Dlx I12b enhancer, this binding evidently is dispensable for IN genesis because we did not detect ectopic expression of Dlx2 or GAD67 in Olig2 À/À animals despite upregulation of Olig1 ( Figure S4 ) (Petryniak et al., 2007 , Furusho et al., 2006 Ono et al., 2008 (Jakovcevski and Zecevic, 2005) , consistent with our findings. OLIG1 and OLIG2 are colocalized to human chromosome 21 in the Down syndrome (DS) critical region, and several studies report they are overexpressed in DS (Bhattacharyya et al., 2009; Chakrabarti et al., 2010) . Certain behavioral and psychiatric disorders are associated with abnormal IN numbers, including Tourette's syndrome (Kalanithi et al., 2005; Kataoka et al., 2010) and schizophrenia (Hashimoto et al., 2003 Lewis et al., 2008) . Our findings raise the possibility that OLIG1 expression becomes dysregulated in certain pathological conditions. Transplantation of progenitors for cortical INs deriving from the MGE can confer increased seizure threshold and alter plasticity (Baraban et al., 2009; Southwell et al., 2010) . Recently, methods to derive human INs and OLs capable of transplantation, widespread migration, and functional integration into mammalian brain have been established (Maroof et al., 2013; Nicholas et al., 2013) . IN transplants attenuate symptoms in rodent models of epilepsy (Baraban et al., 2009; Hunt et al., 2013 ), Parkinson's disease (Martínez-Cerdeñ o et al., 2010) , and neuropathic pain (Brá z et al., 2012) . Based on its properties to repress IN formation in cultured neural progenitors, reducing Olig1 expression (e.g., siRNA) might provide a method to augment IN production for such potential therapeutic applications. Future studies will determine if increased IN number in Olig1 À/À mice leads to differences in inhibitory tone during development, learning and memory tasks, and pathologies such as seizures.
EXPERIMENTAL PROCEDURES Animals
All experimental procedures were approved by the Institutional Animal Care and Use Committee and Laboratory Animal Resource Center at the University of California San Francisco (UCSF). Mouse colonies were maintained at UCSF in accordance with National Institutes of Health and UCSF guidelines. The Olig1 cre/cre (Lu et al., 2002) and Caggs-EGFP (Nakamura et al., 2006) reporter mice have been previously described. The Dlx1/2 fl/fl mice were generated as described in the Supplemental Experimental Procedures.
ISH and IHC
ISH and IHC were performed using standard protocols. Table S1 lists details of antibodies, and protocols for ISH, IHC, and BrdU labeling are provided in the Supplemental Experimental Procedures.
rtPCR RNA was isolated (Trizol extraction followed by RNeasy; QIAGEN) from MGE plus septum, reversed transcribed, and assayed for gene expression by SYBR-Green technology on a Lightcycler 480 (Roche). Primer sequences and details of analytical methods and statistics can be found in the Supplemental Experimental Procedures.
Neural Progenitor Cultures
Neurosphere and neural stem cell monolayer cultures were derived from E14 ventral telencephalon or P3 SVZ by standard methods (Ahlenius and Kokaia, 2010) . Details of culture preparations and western blot analysis of these cultures are provided in the Supplemental Experimental Procedures.
Microscopy, Cell Counting, and Statistical Analyses
Cell populations were quantified in vivo from micrographs of identical field size of anatomically matched regions of somatosensory, motor cortex, and corpus callosum. In vitro cell populations cultured in 8-well culture slides were sampled at defined points within each slide well using a Nikon 80i microscope equipped with a motorized stage. Cell counts were conducted by a researcher blinded to genotype using ImageJ and Nikon Elements software. Statistical significance was determined using unpaired, two-tailed Student's t tests.
DNA Binding and Luciferase Assays
These methods are detailed in the Supplemental Experimental Procedures.
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